About
Jorge Conde is a general partner on the Bio + Health team, where he focuses on life sciences and healthcare investments across therapeutics, diagnostics, tools, and software. Jorge currently serves on the boards of Asimov, Cartography, Dyno, Earli, Komodo Health, and Octant Bio. He has also served on the boards of portfolio companies through their acquisitions including EQRx (by Revolution Medicines), IDRx (by GSK), and Tmunity (by Gilead/Kite).
Prior to joining Andreessen Horowitz, Jorge served as Chief Strategy Officer, Chief Financial Officer, and Chief Product Officer for Syros. Jorge was also cofounder and Chief Executive Officer of Knome, a human genome interpretation company acquired by Tute Genomics in 2015. Before that, Jorge worked in marketing and operations at MedImmune and as a biotechnology investment banker at Morgan Stanley.
Jorge holds an MBA from Harvard Business School, an MS from the Harvard-MIT Division of Health Sciences and Technology, and a BA in biology from Johns Hopkins University. Jorge was named one of the top 35 young innovators in the world by the MIT Technology Review and is a Henry Crown Fellow of the Aspen Institute and a member of the Aspen Global Leadership Network. He previously served on the board of the Museum of Science, Boston.
Born and raised in Miami by Cuban and Peruvian parents, and married to a Madrileña, Jorge and his family live in California. The family cheers for Real Madrid, the Boston Red Sox, and the Miami Dolphins
Latest Content by Jorge
Fueling Innovation with Data with Arif Nathoo
Rare Disease, Big Impact with Matt Wilsey
Bioorthogonal Chemistry with Carolyn Bertozzi
Mastering Data with Sajith Wickramasekara
From Surgeon to Biotech CEO with Jonathan Lim
Adapting Biopharma to AI: A 2024 Update with Greg Meyers
Select Investments
Any investments or portfolio companies mentioned, referred to, or described on this page are not representative of all investments. A list of investments made by funds managed by a16z is available here: https://a16z.com/investment-list/.
Jorge on X
Join the conversation@phylo_bio 🤖🧑🔬 https://t.co/umbuRa7Bq7
But in science, what matters is whether you can trust the…
An early glimpse of this data they just published in @JCO_ASCO was actually the original…
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.